Stelac Advisory Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Stelac Advisory Services's BIIB Position: Q2 2018 in Review
Stelac Advisory Services sold out of Biogen (BIIB) in Q2 2018, closing a stake of 600 shares — an estimated $164K sold.
Stelac Advisory Services first reported a position in BIIB in Q1 2017 and held it in 5 quarters. The position peaked at $191K in Q4 2017. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.
- Stelac Advisory Services reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
- Stelac Advisory Services sold 600 Biogen shares in Q2 2018, an estimated $164K.
- Stelac Advisory Services first reported a position in Biogen in Q1 2017 and held it in 5 quarters.
- Stelac Advisory Services's Biogen position peaked at $191K in Q4 2017.
- 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.
Based on Stelac Advisory Services's 13F filing for Q2 2018, filed 19 Jul 2018.